FY 2019 REVENUES
REVENUES GROWTH IN FY 2019
ONCOLOGY ORDERS GROWTH IN FY 2019
NON-GAAP EPS 1 GROWTH IN FY 2019
Varian (NYSE: VAR) announced today, Proton International at UAB has now treated its first cancer patient with the Varian ProBeam® Compact proton therapy system. The center, a collaboration...
Varian (NYSE: VAR) today announced it was selected to equip the new Ethos Personalized Adaptive Therapy Center in Phoenix, Arizona, and help launch a new era in cancer treatment for patients in...
Varian (NYSE: VAR) today announced its Halcyon™ 2.0 treatment system has been approved by the China National Medical Products Administration (NMPA), which allows the company to market this...
Varian (NYSE: VAR) today announced that the procurement representative of the Quebec government, Groupe d'Approvisionnement Commun de l'Est du Québec (GACEQ), filed a notice of intent to award a...
View all press releases
View all events
Participant Dial-In: 877-407-9708 / 201-689-8259
View more events
Q1 FY20 Earnings Results
View all quarterly results
FY19 Annual Report
FY18 Sustainability Report
View all reports
VP, Treasurer and Investor Relations
1 650 424 6081
Varian Corporate Headquarters
3100 Hansen Way
Palo Alto, CA 94304-1038
Stay up to date on the latest investor information.